Home
>
US Stocks
>
Codiak Biosciences Inc
Codiak Biosciences Inc
CDAK

Codiak Biosciences Inc (CDAK)

$9.149.46%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$8.4
Today Low/High$8.35 / $9.83
52 Week Low/High$8.14 / $32
Market Cap$201.74M

Company Details

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of diseases, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.
OrganisationCodiak Biosciences Inc
HeadquatersSeattle, Washington, US
Employees105
IndustryCommercial Services
CEODouglas Williams

Discover more

Frequently Asked Questions

What is Codiak Biosciences Inc (CDAK) share price today?

Can Indians buy Codiak Biosciences Inc (CDAK) shares?

How can I buy Codiak Biosciences Inc (CDAK) shares from India?

Can Fractional shares of Codiak Biosciences Inc (CDAK) be purchased?

What are the documents required to start investing in Codiak Biosciences Inc (CDAK) stocks?